Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. (Q42980987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

S Ampurdanés

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Olmedo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M D Maluenda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

X Forns

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Costa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J M Sánchez-Tapias

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M T de Anta

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Rodés

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

1 reference

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

827-832

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

Prediction of response to interferon treatment of chronic hepatitis C.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Side effects of alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Eradication of hepatitis C virus RNA after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Factors predictive of the response to interferon in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980285-6

7 January 2021

10.1016/S0168-8278(96)80285-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007709%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference